Le Lézard
Classified in: Health, Science and technology
Subject: PLW

HealthLynked Announces Patent Filing for ARI: A Revolutionary AI-Powered Healthcare Interface


HealthLynked Announces Patent Filing for ARI: A Revolutionary AI-Powered Healthcare Interface

NAPLES, Fla., Oct. 3, 2023 /PRNewswire/ -- HealthLynked Corp. (OTCQB: HLYK)  is thrilled to announce a patent filing for its innovative artificial intelligence (AI) program, ARI (Augmented Real-time Interface). This strategic move highlights HealthLynked's dedication to spearheading advancements in the healthcare domain. With the patent filing in place, HealthLynked expects to launch ARI before the end of 2023, aiming to redefine patient and healthcare provider interactions.

The Importance of Patient Engagement and Updated Medical Information

Engaging patients in their healthcare journey and ensuring that their medical information is up-to-date are critical components in delivering the best possible medical care. Historically, the healthcare system has struggled with the seamless exchange of medical information among healthcare providers. Traditional electronic medical records (EMRs) have been primarily designed with doctors and hospitals in mind, leading to fragmented systems that often compete for clientele rather than collaborate. This competition has resulted in a lack of willingness to integrate, leaving patients with disjointed medical records scattered across various platforms or portals.

HealthLynked stands out in this landscape as the only patient-focused medical record system that prioritizes user control and real-time medical information updating. By placing patients at the center of their healthcare experience, HealthLynked empowers patients to take charge of their health, ensuring that their medical data is accurate, comprehensive, and easily accessible to all of their healthcare providers.

Dr. Michael Dent, CEO of HealthLynked, commented, "AI stands at the forefront of technological advancements poised to dramatically reshape our lives in the coming decades. Its potential is vast and its implications profound. Nowhere is this transformative power more evident than in the realm of healthcare. As we navigate the complexities of modern medicine, AI offers the promise of personalized care, predictive diagnostics, and a level of patient engagement previously unimagined. As we stand on the cusp of this new era, it's clear that the fusion of AI with healthcare will not only redefine patient care but also pave the way for a future where healthcare is more accessible, efficient, and tailored to individual needs."

About ARI

ARI, or Augmented Real-time Interface, is not just another AI system. It is a transformative healthcare companion designed to make healthcare more interactive, personalized, and user-friendly. By leveraging the capabilities of artificial intelligence, ARI promises to offer a unique blend of technology and human touch, ensuring patients receive timely and relevant healthcare advice.

Key Features of ARI

ARI's key features include the following:

By bridging the gap between patients and healthcare providers, HealthLynked's ARI is set to revolutionize the way medical care is delivered, ensuring that every patient receives the best possible recommendations tailored to their unique needs.

About HealthLynked

HealthLynked Corp. is dedicated to enhancing healthcare by facilitating the efficient exchange of medical information between patients and providers. Our cloud-based HealthLynked Network empowers members to actively manage their healthcare, providing a centralized and secure location for their medical data, including medications, allergies, past surgeries, and personal health records.

Healthcare providers in our network benefit from improved patient care and key insights into their practice operations. Additionally, our preferred providers can leverage HealthLynked's marketing tools to engage both patients, ensuring better patient compliance and optimized scheduling. To avail these services, providers need to claim their profiles and complete the necessary steps to become an in-network provider.

For more about HealthLynked Corp., please visit www.healthlynked.com. Stay connected with HealthLynked on Twitter, Facebook, Instagram, and LinkedIn.

Forward-Looking Statements & Risk Factors

This press release contains forward-looking statements that are not based on historical facts. These statements, as defined by the Private Securities Litigation Reform Act of 1995, may differ from actual results, performance, or achievements. Forward-looking statements involve inherent risks and uncertainties. We advise against placing undue reliance on these statements, which are current only as of the date of this press release.

We are not obligated to publicly update any forward-looking statements unless required by law. Any updates should not be interpreted as an indication of additional updates on the same or other topics. For a detailed understanding of the risks and uncertainties related to our operations, please refer to the "Risk Factors" in our latest Annual Report on Form 10-K and other filings with the U.S. Securities and Exchange Commission, available at www.sec.gov.

HLYK Contact:
Mike Paisan
Director of Investor Relations
[email protected]
+1 (800)-928-7144, ext. 123

Note to Editors:
For further information or to schedule an interview with a HealthLynked representative, please contact the Director of Investor Relations at the details provided above.

SOURCE HealthLynked Corp


These press releases may also interest you

at 16:05
Hologic, Inc. announced today the Company's financial results for the fiscal second quarter ended March 30, 2024. "At Hologic we continue to deliver, exceeding the high-end of our guidance for both the top and bottom-line, highlighting our durable...

at 16:05
Expedia Group, Inc. announced financial results today for the first quarter ended March 31, 2024. "Our first quarter results met our guidance with a revenue and earnings beat but with less robust gross bookings. We saw continued momentum in B2B,...

at 16:05
After market close on Thursday, May 30, 2024, NetApp will announce financial results for the fourth quarter and fiscal year 2024 which ended April 26, 2024. NetApp executive management will host a conference call at 2:30 p.m. Pacific Time to...

at 16:05
Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update and reported first quarter 2024 financial results. "I am...

at 16:05
4M Therapeutics Inc., an early-stage biotechnology company developing treatments for neuropsychiatric and neurodegenerative conditions, today announced the formation of its Clinical Advisory Board comprised of five physician scientists and leaders in...

at 16:05
Arrowhead Pharmaceuticals, Inc. today announced a $50 million milestone payment was received from Royalty Pharma plc . This milestone was triggered after the completion of enrollment of the Phase 3 OCEAN(a) - Outcomes Trial of olpasiran, being...



News published on and distributed by: